Insmed Inc. - INSM Net earnings per one share for the last twelve months

Insmed Inc. (INSM) - corporate logo

Insmed Incorporated (INSM) combines deep R&D in lung therapy with the pricing power to set premium prices for unique drugs. This 12-month YoY EPS growth chart helps identify efficiency pivot points, where the current value equals 54.30. The operating model is based on the full outsourcing of production and clinical trials through external contractors.

INSM: insmed.com Net earnings per share for the last 12 months 02/11/2024 - 11/16/2026

Insmed Incorporated - analytical breakdowns and key metrics (INSM)

- stock quotes and analyst forecast:
- issuer market value details:
Fundamental company valuation:INSM - Insmed Inc.
Brand item of Insmed Corp

Insmed Incorporated specializes in the development of orphan drugs, demonstrating high resilience to macroeconomic shocks. By analyzing the current state of annual EPS TTM growth, an investor can see the percentage change in earnings per share over a rolling twelve-month period. Daily recalculation of this metric smooths out quarterly report volatility, revealing the actual trajectory of business efficiency. The stable trend of this indicator confirms the fundamental value of the company regardless of market cyclicality.

Competitor analysis

Earnings per one share for the last 12 months VRTX|ALNY: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months United Therapeutics Corp. (UTHR)|BMRN (BioMarin) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BBIO (BridgeBio)|Earnings per share for the last twelve months bgm.ltd (BGM)|COGT (Cogent Biosciences Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months Xeris Biopharma Holdings XERS|KROS (Keros Pharma) - Earnings per one share for the last 12 months|Arcturus Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ETON (Eton Pharmaceuticals)|KMDA: Net earnings per share (EPS TTM)|Fulcrum Therapeutics Inc (FULC) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months abeonatherapeutics.com|MREO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PLX|Net earnings per share for the last 12 months Pliant Therapeutics, Inc. PLRX|Net earnings per share (EPS TTM) APLT (Applied Therapeutics Inc.)|Net earnings per share (EPS TTM) Rein Therapeutics Inc. RNTX|gelteq.com - Net earnings per share (EPS TTM)|AYTU - Net earnings per share (EPS TTM)|CMMB: Net earnings per share (EPS TTM)|SRx Health Solutions Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Polyrizon Ltd|AEZS (Aeterna Zentaris) - Earnings per share for the last four quarters|Earnings per share for the last twelve months CTD Holdings (CYTH)|INZY: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Reneo Pharmaceuticals Inc. RPHM|Net earnings per share for the last four quarters COSCIENS Biopharma Inc. (CSCI)